<DOC>
	<DOCNO>NCT02161198</DOCNO>
	<brief_summary>Y-75/ginsan acidic polysaccharide molecular weight 150,000 Da , isolate aqueous Korean Panax ginseng extract . Preclinical laboratory study show function immunomodulatory molecule . The present study perform evaluate safety beneficial effect Y-75 immune function group healthy adult . The focus trial modulation innate immunity , comprise cytotoxic activity natural killer cell , phagocytic activity polymorphonuclear leukocyte mononuclear phagocyte , serum level monocyte-derived mediator .</brief_summary>
	<brief_title>Efficacy Safety Study Ginseng Polysaccharide Extract</brief_title>
	<detailed_description />
	<criteria>Good general health human immunodeficiency virus1 infection malignancy active cardiovascular , renal , pulmonary , hepatic , neurological , psychiatric disease recent ( within 4 week ) acute respiratory tract symptom immunosuppressive therapy include cytotoxic agent corticosteroid medication ( within 4 week ) deem likely interfere evaluation history allergic adverse reaction ginseng product</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>Panax ginseng CA</keyword>
	<keyword>ginsan</keyword>
	<keyword>polysaccharide</keyword>
	<keyword>immunity</keyword>
	<keyword>natural killer cell</keyword>
</DOC>